Project Grant R01DE033232

Award Date 8/12/24
Completion Date 5/31/29
Dollars Obligated $1.9M
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate functional amyloid formation in the oral bacterium Streptococcus mutans. The total funding amount is $505,530 and the award period runs from September 16, 2024 to September 15, 2025. The key research objectives include: (1) exploring the relationships between S. mutans amyloid-forming...
This federal Project Grant award of $460,885 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research on how the fungus Candida albicans interacts with the bacterium Streptococcus mutans to enhance the formation and virulence of cariogenic biofilms. The primary objectives are to identify the transcription factors and protein kinases in Candida albicans that regulate its interactions with...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate the mechanisms of integrative and conjugative elements (ICEs) in the oral bacterium Streptococcus mutans. The $1,072,058 award to Arkansas State University will enable the research team, in collaboration with a sub-awardee at Purdue University, to dissect the regulatory mechanisms controlling...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $163,411 to The Ohio State University to conduct research on the interactions between the oral bacterium Streptococcus mutans and other commensal oral streptococcal species. The research aims to elucidate the nutritional niches and carbohydrate utilization preferences of these microbes within oral biofilms, with...
This Project Grant award of $310,500.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program, supports a comparative experimental evolution study on gene essentiality in the oral bacteria Streptococcus sanguinis and S. mutans. The research aims to categorize the essential genes in S. mutans, identify and classify suppressor mutations for its evolvable essential genes, and compare the findings...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a systematic functional genomics analysis of the oral pathogen Streptococcus mutans. The $838,322 award, granted on Sep 24, 2024, will enable Arkansas State University to: Construct an arrayed and sequence-defined transposon mutant library for S. mutans to systematically identify infection-relevant genes. Study the...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $5,700,915 to the Regents of the University of Michigan to develop a new class of anti-caries therapy. The key products and services to be delivered include: Developing fluoride efflux inhibitors that potentiate the antimicrobial effects of fluoride and inhibit the growth of oral pathogens like Streptococcus mutans and...
This $431,750 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to decipher the mechanisms by which two proteins, AAFLP-1 and AADCUB, regulate the production of exopolysaccharide (PNAG) in the oral bacterium Aggregatibacter actinomycetemcomitans. The research aims to investigate how these two proteins, which are unique to A. actinomycetemcomitans, independently...
This Project Grant award, valued at $470,279.00 and awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research on the impact of bacterial oxidative stress responses on the ecology and pathogenicity of oral streptococci. The key goals are to identify and characterize the mechanisms by which oral streptococci, including the health-associated Streptococcus sanguinis and the caries-associated...
This Project Grant award of $310,000.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) federal grant program, will fund research to identify natural products synthesized by Streptococcus mutans bacteria that can kill the pathogen Enterococcus faecalis. The research aims to determine if S. mutans biofilms producing these natural products can exclude E. faecalis from invading pre-formed biofilms and shape the...

This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $1,865,330.00 to the University of Alabama at Birmingham (UAB) to conduct structural and functional studies on the glucosyltransferase (GTF) enzymes of the dental caries pathogen Streptococcus mutans. The research aims to determine the specific molecular mechanisms by which S. mutans's GTFs produce soluble and insoluble glucans, which are crucial for biofilm formation, bacterial colonization, and virulence. The project involves: (1) determining the structures of GTFs GTFB and GTFD, (2) elucidating the catalytic mechanism of S. mutans's GTFs, and (3) characterizing the role of the sucrase site, polymerization site, and glucan binding domains on biofilms, colonization, and virulence. The findings are expected to provide a mechanistic foundation for the 800+ GH70 hydrolases and explore innovative strategies to address the cariogenic dysbiosis mediated by S. mutans's GTFs. The project period runs from August 12, 2024 to May 31, 2029.

A sub-award of $541,478 was made to Oregon Health & Science University to contribute to the structural and functional studies on the S. mutans GTFs.

Generated 8/5/25, 2:48 AM